Francesco Marampon

Pubblicazioni

Titolo Pubblicato in Anno
Surgery‐ineligible elderly patients with cutaneous squamous cell carcinoma of the head and neck region gain clinical benefit from definitive weekly hypofractionated radiotherapy HEAD & NECK 2023
Current status and perspectives of interventional clinical trials for brain metastases: analysis of ClinicalTrials.gov RADIATION ONCOLOGY 2023
The evolving role of reirradiation in the management of recurrent brain tumors JOURNAL OF NEURO-ONCOLOGY 2023
Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status JOURNAL OF NEURO-ONCOLOGY 2023
ATX-101, a peptide targeting PCNA, has antitumor efficacy alone or in combination with radiotherapy in murine models of human glioblastoma CANCERS 2022
The botanical drug PBI-05204, a supercritical CO2 extract of nerium oleander, is synergistic with radiotherapy in models of human glioblastoma FRONTIERS IN PHARMACOLOGY 2022
MET inhibition sensitizes rhabdomyosarcoma cells to NOTCH signaling suppression FRONTIERS IN ONCOLOGY 2022
Anti‑oncogenic and pro‑myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma ONCOLOGY REPORTS 2022
Abstract 6307: The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, augments the antitumor efficacy of radiotherapy in treatment of human glioblastoma CANCER RESEARCH 2022
Radioresistance in rhabdomyosarcomas: much more than a question of dose FRONTIERS IN ONCOLOGY 2022
Translational implications for radiosensitizing strategies in rhabdomyosarcoma INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo FRONTIERS IN PHARMACOLOGY 2022
Radioresistance Mechanisms in Prostate Cancer Cell Lines Surviving Ultra-Hypo-Fractionated EBRT: Implications and Possible Clinical Applications CANCERS 2022
Safety and efficacy of combining afatinib and whole-brain radiation therapy in treating brain metastases from EGFR-mutated NSCLC: a case report and literature review BJR CASE REPORTS 2022
The prostacyclin analogue Iloprost modulates CXCL10 in systemic sclerosis INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors CELLS 2022
Radioresistance Mechanisms in Prostate Cancer Cell Lines Surviving Ultra-Hypo-Fractionated EBRT: Implications and Possible Clinical Applications CANCERS 2022
New Insights on the Nuclear Functions and Targeting of {FAK} in Cancer INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022
A pilot surveillance investigation on the influence of a probiotic combination on side-effects caused by common anti-cancer therapies Reports of Practical Oncology Radiotherapy 2022
Phosphodiesterase type-5 inhibitor tadalafil modulates steroid hormones signaling in a prostate cancer cell line INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2021

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma